Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Acta Dermato-Venereologica
|
March 14, 2023
Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review
Diva Amiri, Christopher Willy Schwarz, Lise Gether, et al.
JAMA Dermatology
|
June 18, 2024
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis: A Meta-analysis
Gustav Hjort, Christopher Willy Schwarz, Lone Skov, et al.
Acta Dermato-Venereologica
|
August 28, 2020
Effect of Anti-interleukin-17 Treatment on Haemoglobin A1c Levels
Christopher Willy Schwarz, Nikolai Dyrberg Loft, Claus Zachariae, et al.
Dermatology (Basel, Switzerland)
|
October 13, 2020
Are Systemic Corticosteroids Causing Psoriasis Flare-Ups? Questionnaire for Danish Dermatologists, Gastroenterologists and Rheumatologists
Christopher Willy Schwarz, Nikolai Loft, Vibeke Andersen, et al.
Clinical and Experimental Medicine
|
June 25, 2025
Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis
Daniel Isufi, Christopher Willy Schwarz, Mikkel Bak Jensen, et al.
JAMA Dermatology
|
October 22, 2025
Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab
Christopher Willy Schwarz, Mads Kirchheiner Rasmussen, Trine Bertelsen, et al.
Dermatology (Basel, Switzerland)
|
August 10, 2025
No Change in HbA1c Levels During Treatment with Biologics or Methotrexate in Patients with Psoriasis
Maheen Fatima Bukhari, Christopher Willy Schwarz, Claus Otto Carl Zachariae, et al.
The Journal of Dermatology
|
August 27, 2024
HLA-C*06:02 in Danish patients with psoriasis and response to biological treatment
Mie Siewertsen Bergmann, Nikolai Loft, Christopher Willy Schwarz, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
September 20, 2024
Characteristics of Patients With Psoriasis Treated With Various Biologics - A Danish Cohort Study
Christopher Willy Schwarz, Lone Skov, Alexander Egeberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 6, 2025
Real-world experience of multiple switches between adalimumab biosimilars in patients with psoriasis
Ole Krogh-Jensen, Christopher Willy Schwarz, Diljit Kaur-Knudsen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Acta Dermato-Venereologica
|
March 14, 2023
Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review
Diva Amiri, Christopher Willy Schwarz, Lise Gether, et al.
JAMA Dermatology
|
June 18, 2024
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis: A Meta-analysis
Gustav Hjort, Christopher Willy Schwarz, Lone Skov, et al.
Acta Dermato-Venereologica
|
August 28, 2020
Effect of Anti-interleukin-17 Treatment on Haemoglobin A1c Levels
Christopher Willy Schwarz, Nikolai Dyrberg Loft, Claus Zachariae, et al.
Dermatology (Basel, Switzerland)
|
October 13, 2020
Are Systemic Corticosteroids Causing Psoriasis Flare-Ups? Questionnaire for Danish Dermatologists, Gastroenterologists and Rheumatologists
Christopher Willy Schwarz, Nikolai Loft, Vibeke Andersen, et al.
Clinical and Experimental Medicine
|
June 25, 2025
Risk of new or recurrent cancer during treatment with biologics in patients with immune-mediated inflammatory diseases and previous cancer: a meta-analysis
Daniel Isufi, Christopher Willy Schwarz, Mikkel Bak Jensen, et al.
JAMA Dermatology
|
October 22, 2025
Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab
Christopher Willy Schwarz, Mads Kirchheiner Rasmussen, Trine Bertelsen, et al.
Dermatology (Basel, Switzerland)
|
August 10, 2025
No Change in HbA1c Levels During Treatment with Biologics or Methotrexate in Patients with Psoriasis
Maheen Fatima Bukhari, Christopher Willy Schwarz, Claus Otto Carl Zachariae, et al.
The Journal of Dermatology
|
August 27, 2024
HLA-C*06:02 in Danish patients with psoriasis and response to biological treatment
Mie Siewertsen Bergmann, Nikolai Loft, Christopher Willy Schwarz, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
September 20, 2024
Characteristics of Patients With Psoriasis Treated With Various Biologics - A Danish Cohort Study
Christopher Willy Schwarz, Lone Skov, Alexander Egeberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 6, 2025
Real-world experience of multiple switches between adalimumab biosimilars in patients with psoriasis
Ole Krogh-Jensen, Christopher Willy Schwarz, Diljit Kaur-Knudsen, et al.
Page
of 2